Regulatory roadblocks have fallen
Since March, the Trump Administration has taken a number of steps
to lift regulatory restrictions and ease reimbursement policies around telemedicine, with the aim of blunting the spread of the novel coronavirus. It makes good sense for triaging care while limiting exposure, and is reviving a technology that had, prior to the pandemic, so far failed to take off.
Five years back, when telemedicine was a promising new technology, physician interest stood at 47% in the U.S., and 13% of physicians reported having already conducted a virtual consult.
Virtual consultation use and interest over time:
Source: Taking the Pulse® U.S. 2016-2020
Since then, however, there has been significant erosion in physician interest as the promise of telemedicine collided with a raft of state restrictions limiting reimbursement, along with a lack of a clear standout platform for tele-consults.